Bendamustine Production Cost Reports

The report provides a detailed analysis essential for establishing a bendamustine production plant. It encompasses all critical aspects necessary for bendamustine production, including the cost of bendamustine production, bendamustine plant cost, bendamustine production costs, and the overall bendamustine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a bendamustine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Bendamustine is a chemotherapy drug that is mainly used in the treatment of certain types of blood cancers. It is commonly used in the treatment of conditions such as chronic lymphocytic leukaemia (CLL), non-Hodgkin lymphoma, and multiple myeloma. It works by damaging the DNA of cancer cells, which helps slow down or stop their growth. It is often used in hospitals and oncology centres as part of cancer therapy, either alone or in combination with other medicines, to improve treatment outcomes. It is also being studied for its potential in treating multiple myeloma and other forms of cancer. It serves as an important drug for the treatment of cases where patients do not respond well to other chemotherapy drugs. In addition, it is used in research and pharmaceutical production for developing advanced cancer treatment options.

The demand for bendamustine is driven by its application as an antineoplastic agent for treating certain types of cancer, particularly blood-related cancers, which fuels its market expansion. Its application as a chemotherapy medication in the treatment of chronic lymphocytic leukaemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma significantly boosts its demand in the medical and pharmaceutical industries. Its application as a chemotherapy agent in combination with other antineoplastic agents for the treatment of refractory forms of non-Hodgkin lymphoma also supports its demand in the oncology and healthcare sectors. Its demand as a valuable medicine in modern oncology for controlling and treating blood-related cancers also boosts its market growth. Emerging markets in the Asia Pacific and other regions with improved healthcare infrastructure and access to advanced treatments also contribute to its market demand. Factors that influence industrial bendamustine procurement include regulatory compliance for production quality, cost pressures from generic competition, and the need for reliable suppliers. Logistics efficiency to maintain stable supply chains in the pharmaceutical industry, availability and cost of active pharmaceutical ingredients, strict regulatory approvals, and advancements in drug formulation also impact its procurement decisions.

Raw Material for Bendamustine Production

According to the bendamustine production plant project report, the major raw materials for bendamustine production include ethyl 5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoate, thionyl chloride, and hydrochloric acid.

Production Process of Bendamustine

The extensive bendamustine production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of bendamustine hydrochloride begins with the reaction of ethyl 5-(bis(2-hydroxyethyl)amino)-1-methyl-1H-benzimidazole-2-butanoate with thionyl chloride in dichloromethane at low temperature, which converts the hydroxyethyl groups into chloroethyl groups. After removing excess reagents and solvent under vacuum, the intermediate is treated with hydrochloric acid and water at elevated temperature to hydrolyse the ester group, forming the crude hydrochloride salt. Activated carbon is used for purification before concentrating the solution. Then, crystallisation is induced by cooling the aqueous solution, and the solid is filtered and washed with water and acetone. The final product is collected by filtration, washed, and vacuum-dried to obtain high-purity bendamustine hydrochloride as the final product.

Bendamustine is a bifunctional mechlorethamine derivative that belongs to the class of nitrogen mustard alkylating agents. It appears as a white-to-off-white microcrystalline powder with amphoteric properties. The molecular formula of the compound is C16H21Cl2N3O2, and its molar mass is 358.26 g/mol. Its density is approximately 1.3 g/cm³, and the compound has a melting point of 152-156 degrees Celsius. The boiling point of the compound is approximately 585.2 degrees Celsius at 760 mmHg. It is soluble in water and also demonstrates solubility in methanol, DMSO, and ethanol. The compound functions as an alkylating agent, which causes intra-strand and inter-strand cross-links between DNA bases. It is a known hazardous substance that can cause fetal harm when administered to a pregnant woman. Extended exposure may lead to serious adverse effects, including low blood cell counts, allergic reactions, and increased risk of infection. It is recommended to handle the compound with appropriate protective equipment and follow strict safety protocols during preparation and administration.